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Occult breast cancer has frequently been described as presenting as axillary lymph node metastases but rarely as gastrointestinal
metastases, Varadarajan et al. (2007). In extremely rare situations, cancerous lesions identiﬁed in the gastrointestinal tract have
been determined to be metastatic lesions from primary breast cancers, Taal et al. (2000). We report a case of an occult lobular
adenocarcinoma presenting as gastrointestinal metastases. It is essential that the possibility of lesions found in the gastrointestinal
tract originating from distant or occult cancers be considered in order that appropriate therapeutic options may be discussed and
considered early after diagnosis.
Copyright © 2009 Lonzetta Neal et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Breastcarcinomaisthemostcommonmalignancyinwomen
after skin cancer and, after lung cancer, the most frequent
cause of cancer death in females. Over 175,000 women were
diagnosed with breast cancer in 2007 and more than 40,000
died from the disease. With advancements in screening
over the past 25 years, fewer than ten percent of patients
will present with metastatic breast carcinoma at the time
of diagnosis. However, despite improvements in surgical
and chemotherapeutic therapies, women with early-stage
and locally advanced breast cancer relapse not infrequently,
usually presenting with distant metastatic disease. Metastatic
disease of breast cancer origin commonly appears in the
skeleton (43%), stomach (27%), lung (8%), and liver (4%)
[1]. Occult breast cancer (OBC) can rarely manifest as
axillary nodal metastases with an incidence of 0.3% to 1%
[2], and, of those female patients presenting with adeno-
carcinoma within an axillary lymph node, breast cancer is
most likely the primary source [3]. Gastrointestinal (GI)
tract metastasis and carcinomatosis from primary breast
cancer are rare. Data from two series, including surgical
and autopsy specimens targeting the gastrointestinal tract,
reported metastatic breast cancer occurred in this site at a
rate of 8% to 35% [4, 5].
Our review of the literature revealed one case report of
occultbreastcarcinomapresentingasapancreatictumor[6].
We report a case of an occult breast cancer presenting with
gastrointestinal metastasis.
2.Background
2.1. Case Report. A 53-year-old female presented to an
outside institution with a one-month complaint of abdom-
inal pain. An extensive evaluation was only remarkable for
an umbilical hernia and a chest wall nodule. The chest
wall nodule was excised and reported as benign. Screening
colonoscopy was negative except for a reportedly benign
colon polyp that was removed. She underwent an umbilical
herniarepairwithmeshplacement.Herpostoperativecourse
was complicated by omental herniation under the mesh
with omental infarction and intraperitoneal bleeding. She
underwent repair of this process but continued to feel
anorexic and ill. Five months following her initial operation,
she developed borborygmi associated with watery diarrhea
occurring up to ten times a day.
An upper gastrointestinal endoscopic study with biopsies
o ft h ea n t r u mw a sp e r f o r m e d .N oe v i d e n c eo fH. pylori
or celiac sprue was noted. The biopsy revealed metastatic2 Case Reports in Medicine
Figure 1: Gastric biopsy. Inﬁltrating tumor cells (arrow) involving
gastric antrum wall (hematoxylin and eosin). Original magniﬁca-
tion ×200.
Figure 2: Gastric biopsy. Numerous cytokeratin 7, CK7-positive
tumor cells inﬁltrating gastric wall. Original magniﬁcation ×200.
carcinoma consistent with a breast primary. Estrogen recep-
tor was strongly positive and progesterone receptor was
negative. HER2 was negative by FISH. She oﬀered no breast
complaints at the time of diagnosis. Clinical examination of
the breasts and axillae was normal. Screening mammograms
performed previously showed heterogeneously dense nodu-
lar parenchyma bilaterally. Minimal architectural distortion
was present in the superior portion of the left breast but this
was previously noted and felt to be benign. Family history
was remarkable for a maternal aunt and a paternal aunt with
postmenopausal breast carcinoma.
Given her unusual pathology, all of her prior pathology
wassenttoourinstitutionforreview.Thepreviouslyresected
colon polyp and chest wall lesion were reevaluated and
found to be consistent with metastatic breast carcinoma.
She underwent a bilateral breast MRI examination, which
showed no worrisome areas of focal enhancement. She was
then started on with hormonal therapy with an aromatase
inhibitor.
Figure 3: Chest wall lesion. Inﬁltrating estrogen receptor, ER-
positive tumor cells amongst ﬁbrous septa consistent with
metastatic breast carcinoma. Original magniﬁcation ×100.
3.Pathological Findings
The stomach biopsy specimen showed metastatic carcinoma
consistent with breast primary. Immunohistochemical stains
CK7, CK20, CD45, CDX2, estrogen receptor (ER), pro-
gesterone receptor (PR), and HER2 were performed. The
neoplastic cells were ER positive (>95% nuclear staining),
PRweaklypositive(10%nuclearstaining),andCK7positive.
Tumor stainings for HER2, CK20, CD45, and CDX2 were
negative. The pattern of tumor inﬁltration, morphology and
immunohistochemical proﬁles were consistent with lobular
breast carcinoma. The stomach lesion exhibited a linitus
plastica appearance.
The chest wall lesion was also consistent with metastatic
breast carcinoma which was ER positive, PR weakly positive,
and equivocal for HER2 (score 2+) with negative HER2 gene
ampliﬁcation by FISH.
4. Discussion
Occultbreastcarcinomamayrarelypresentasaxillarymetas-
tasis [2]; however, presentation as gastrointestinal metastasis
has never been described. Metastases from gastrointestinal
systemhavebeenreportedafterapreviousdiagnosisofbreast
carcinoma within a period of months to years between the
original diagnosis of breast cancer and recurrence in the
gastrointestinal tract [1, 7]. Symptoms of gastrointestinal
metastases can be very nonspeciﬁc in their presentation.
In this case report, the gastrointestinal metastasis was an
incidental ﬁnding, and retrospective review of histology
revealed that this was of breast origin.
The metastatic patterns of lobular and ductal carcinoma
have been reported to diﬀer considerably. Metastatic breast
carcinomas of ductal origin usually present with hepatic,
lung, brain, and bone metastases whereas metastatic lobular
carcinoma is noted to spread to gastrointestinal, gyneco-
logical, and peritoneal structures [8]. Autopsy series report
the distribution of gastrointestinal metastases as follows:Case Reports in Medicine 3
esophagus (25%), stomach (25%), small intestine (28%),
colon (19%), and rectum (4%) [5].
Cormier et al. [9] reported six patients with linitis
plastica attributable to metastatic breast cancer. All six cases
were associated with lobular breast carcinoma. A 30-year
review by the same group revealed 25 additional cases in
whichlobularcarcinomaandlinitisplasticaduetometastasis
occurredmetachronouslyorsynchronouslyinpatients.Most
of the women (74%) had metastasis within 5 years of the
initial diagnosis of breast cancer; however, four patients
presented with metastatic gastric disease more than 10 years
after the identiﬁcation of the primary breast cancer [9].
McLemore et al. [10] found that 73 patients out of 12,001
with metastatic disease secondary to breast cancer had GI
tractinvolvement.Themeanintervalbetweenprimarybreast
cancers to GI presentation was 7 years. However, 16% of
patients were found to have peritoneal metastatic disease at
the time of their breast cancer diagnosis.
Abdominal pain was found to be the most common
symptom of breast cancer metastatic to the gastrointestinal
tract, followed by bloating, melena, GI hemorrhage, bowel
obstruction, early satiety, dysphagia, weight loss, anemia,
fatigue, and a palpable abdominal mass [10].
Metastatic breast cancer can easily be mistaken for a
primary gastrointestinal cancer [11, 12]. Schwartz et al. [11]
found that seven patients who presented with gastrointesti-
nal symptoms were initially thought to have primary GI
cancer, one with a nearly obstructing colon tumor. These
patients were found to have primary breast cancer after
subsequent comparisons with prior breast specimens.
Metastatic breast cancer can be diﬃcult to distinguish
from primary gastric cancer. Metastasis to the stomach
from lobular type carcinoma tends to exhibit tumor cells
that are inﬁltrating in single ﬁle process between benign
gastric glands. Signet cells may be occasionally noted. This
histologic ﬁnding resembles primary diﬀu s et y p eg a s t r i c
carcinomas (linitis plastica). Metastasis from ductal type
carcinoma can resemble poorly diﬀerentiated intestinal
type gastric adenocarcinomas [11]. Immunohistochemical
markers for estrogen receptor and diﬀerential cytokeratin
expression (cytokeratin 7 and cytokeratin 20) can allow
accurate diagnosis. It is important to make the distinction
between a primary or a metastatic breast carcinoma. The
administration of chemotherapy and hormonal therapy can
signiﬁcantly improve the survival in patients with metastatic
breast carcinoma [9, 10]. There is a palliative role for surgery
for the relief of symptoms such as pain from mass eﬀect,
obstruction,ordysphagia.Ingeneral,gastricmetastasesfrom
breast cancer reﬂect a poor prognosis despite chemotherapy
and hormonal therapy. Median survival time from the time
of diagnosis of metastases was noted to be approximately 28
months [10].
5. Conclusion
It is important for physicians who follow survivors of
invasive lobular carcinoma of the breast to remember
that gastrointestinal symptoms can be a manifestation of
metastatic disease. The disease free interval between primary
breast cancer and gastrointestinal involvement may be as
long as 10 years from the time of diagnosis. In our unique
case, the breast primary was not found. Once the correct
diagnosis is made, targeted systemic treatment speciﬁc for
breast cancer may be considered and initiated if appropriate.
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